Genesis Therapeutics is committed to unifying artificial intelligence and biotechnology to discover innovative treatments for patients suffering from severe conditions. At the forefront of small molecule drug discovery, Genesis leverages its proprietary AI platform, GEMS, to optimize and accelerate the drug development process. Through deep learning and molecular simulations, the company aims to tackle both data-poor and undruggable targets, enhancing the pipeline for groundbreaking therapeutics.
Company benefits
Challenging, high impact ML research deployed to accelerate drug discovery
Strong technical coworkers in AI, software, and chemistry who are intellectual curious and humble
Team discussions on ML or chemistry papers weekly to inspire new ideas